Clinical Trial Update: Effect of Netazepide on Omeprazole-induced Changes in Chromogranin A and Gastrin [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating netazepide's effect on omeprazole-induced changes in Chromogranin A and gastrin, focusing on ECL-cell hyperplasia, parietal-cell hype…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia
• Ecl-cell Hyperplasia
• Parietal-cell Hyperplasia
• Rebound Hyperacidity

Drugs mentioned

• Netazepide (netazepide)

Snippet

Sponsor: Trio Medicines Ltd. | Conditions: ECL-cell Hyperplasia, Parietal-cell Hyperplasia | Phase 1 | Status: COMPLETED